John Raiss, MDDr. Raiss has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
What is the best approach to treatment of adolescents with eating disorders? What level of care should be we advocating for to have the best chance of a good outcome? This review of the recent Canadian Eating Disorders Guidelines offers a clear direction for our efforts to provide better care.
Kristen Gardner, PharmD. Dr. Gardner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
A randomized, double- blind, placebo-controlled trial studying the effects of olanzapine on change in body weight and obsessionality in adult outpatients with anorexia nervosa. Although strength of the study includes its large sample size, it is undetermined if patient weight gain is due to a therapeutic effect on anorexia or to olanzapine’s known metabolic effects.